当前位置: X-MOL 学术Pharmacol. Therapeut. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long non-coding RNAs as new regulators of cardiac electrophysiology and arrhythmias: Molecular mechanisms, therapeutic implications and challenges.
Pharmacology & Therapeutics ( IF 13.5 ) Pub Date : 2019-07-02 , DOI: 10.1016/j.pharmthera.2019.06.011
Yong Zhang 1 , Weijie Du 1 , Baofeng Yang 2
Affiliation  

Long non-coding RNAs (lncRNAs or lncRs) as a new class of regulatory transcripts have been intensively studied for their roles in cardiovascular biology in the past decade. We now know that lncRNAs are significantly implicated in diverse cardiovascular conditions and associated risk factors, including myocardial infarction, coronary heart disease, atherosclerosis/coronary artery disease, vascular disease, cardiac hypertrophy, heart failure, etc. Though in its early stage, research on control of cardiac electrophysiology by lncRNAs has generated some interesting observations and mechanistic insight of significant relevance to translational medicine. This review article focuses on lncRNA regulation of cardiac electrophysiology and arrhythmias with brief discussion on some fundamental aspects of relevant background information for better understanding of the subject. It provides critical analysis of published studies in the literature together with unpublished observations from our own laboratories. In addition to discuss the phenotypes associated with deregulation of lncRNAs, we also try to dissect out the cellular and molecular mechanisms for lncRNAs as regulators of arrhythmogenesis. This review then further touches on the therapeutic implications of lncRNAs and potential strategies for the development of lncRNA-based drugs. Finally, future directions to lncRNA research on cardiac electrophysiology and arrhythmias are anticipated.

中文翻译:

长非编码RNA作为心脏电生理和心律不齐的新调节剂:分子机制,治疗意义和挑战。

在过去的十年中,人们对长非编码RNA(lncRNA或lncRs)作为一类新的调控转录本进行了深入研究。我们现在知道,lncRNAs与多种心血管疾病和相关的危险因素密切相关,包括心肌梗塞,冠心病,动脉粥样硬化/冠状动脉疾病,血管疾病,心脏肥大,心力衰竭等。 lncRNAs对心脏电生理的控制已产生了一些有趣的观察结果,并且对与转化医学具有重大意义的机理有深刻的见解。这篇综述文章着重于心脏电生理和心律失常的lncRNA调控,并简要讨论了相关背景信息的一些基本方面,以更好地理解该主题。它提供了对文献中已发表研究的批判性分析,以及我们实验室未发表的观察结果。除了讨论与lncRNA失控相关的表型,我们还尝试剖析lncRNA作为心律失常调节因子的细胞和分子机制。然后,本文将进一步探讨lncRNA的治疗意义以及基于lncRNA的药物开发的潜在策略。最后,预期了有关心脏电生理和心律不齐的lncRNA研究的未来方向。它提供了对文献中已发表研究的批判性分析,以及我们实验室未发表的观察结果。除了讨论与lncRNA失控相关的表型,我们还尝试剖析lncRNA作为心律失常调节因子的细胞和分子机制。然后,本文将进一步探讨lncRNA的治疗意义以及基于lncRNA的药物开发的潜在策略。最后,预期了有关心脏电生理和心律不齐的lncRNA研究的未来方向。它提供了对文献中已发表研究的批判性分析,以及我们实验室未发表的观察结果。除了讨论与lncRNA失控相关的表型,我们还尝试剖析lncRNA作为心律失常调节因子的细胞和分子机制。然后,本文将进一步探讨lncRNA的治疗意义以及基于lncRNA的药物开发的潜在策略。最后,预期了有关心脏电生理和心律不齐的lncRNA研究的未来方向。然后,本文将进一步探讨lncRNA的治疗意义以及基于lncRNA的药物开发的潜在策略。最后,预期了有关心脏电生理和心律不齐的lncRNA研究的未来方向。然后,本文将进一步探讨lncRNA的治疗意义以及基于lncRNA的药物开发的潜在策略。最后,预期了有关心脏电生理和心律不齐的lncRNA研究的未来方向。
更新日期:2019-11-18
down
wechat
bug